Mark Wunderlich
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Molecular Biology top 2%
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
Papers in
- Hematology 58
- Acute Myeloid Leukemia Research 50
- Hematopoietic Stem Cell Transplantation 10
-
- Protein Degradation and Inhibitors 16
- Histone Deacetylase Inhibitors Research 13
- RNA Interference and Gene Delivery 6
- Ubiquitin and proteasome pathways 5
- Co-authors
- James C. Mulloy (61 shared papers)Christopher R. Vakoc (2 shared papers)Amy Rappaport (1 shared paper)Katharina Blatt (1 shared paper)Eric Wang (1 shared paper)Peter Valent (1 shared paper)Jun Qi (1 shared paper)Daniel Magoon (1 shared paper)
- Journals
- Blood (28 papers)Leukemia (7 papers)Journal of Clinical Investigation (6 papers)Blood Advances (4 papers)Proceedings of the National Academy of Sciences (4 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Mark Wunderlich
91 papers receiving 4.3k citations
Mark Wunderlich's Hit Papers
Peers
Comparison fields: 5 of 103
- Hematology 1.8k
- Molecular Biology 2.8k
- Immunology 622
- Genetics 303
- Cancer Research 410
Countries citing papers authored by Mark Wunderlich
This map shows the geographic impact of Mark Wunderlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wunderlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wunderlich more than expected).
Fields of papers citing papers by Mark Wunderlich
This network shows the impact of papers produced by Mark Wunderlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wunderlich. The network helps show where Mark Wunderlich may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Wunderlich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Hit paper breakdown → | 2011 | 1447 |
| 2 | 2008 | 239 | |
| 3 | 2013 | 158 | |
| 4 | 2013 | 152 | |
| 5 | 2020 | 121 | |
| 6 | 2010 | 111 | |
| 7 | 1996 | 109 | |
| 8 | 2015 | 95 | |
| 9 | 2015 | 89 | |
| 10 | 2012 | 88 | |
| 11 | 2023 | 84 | |
| 12 | 2002 | 79 | |
| 13 | 2007 | 75 | |
| 14 | 2013 | 73 | |
| 15 | 2018 | 73 | |
| 16 | 2010 | 61 | |
| 17 | 2001 | 60 | |
| 18 | 2005 | 57 | |
| 19 | 2013 | 55 | |
| 20 | 2011 | 53 |
About Mark Wunderlich
Mark Wunderlich is a scholar working on Hematology, Molecular Biology, Immunology, Oncology and Public Health, Environmental and Occupational Health, having authored 92 papers that have together received 4.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (50 papers), Protein Degradation and Inhibitors (16 papers), Histone Deacetylase Inhibitors Research (13 papers), Immune Cell Function and Interaction (12 papers), Hematopoietic Stem Cell Transplantation (10 papers), Acute Lymphoblastic Leukemia research (10 papers), RNA Interference and Gene Delivery (6 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Hematology (1.8k citations), Molecular Biology (2.8k citations), Immunology (622 citations), Genetics (303 citations) and Cancer Research (410 citations). Mark Wunderlich has collaborated with scholars based in United States, China and France. Frequent co-authors include James C. Mulloy, Christopher R. Vakoc, Amy Rappaport, Katharina Blatt, Eric Wang, Peter Valent, Jun Qi, Daniel Magoon, Junwei Shi and Edward Allan R. Sison. Their work appears in journals such as Blood, Leukemia, Journal of Clinical Investigation, Blood Advances and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.